CONCORDIA UK

Concordia UK develops, licenses, and markets generic pharmaceutical products. It also manages and markets generic and branded pharmaceutical products of other companies. Concordia UK markets products through its sales, marketing, and distribution team in Europe. It began operation as Focus Pharmaceuticals in 2002. Concordia UK's headquarters is in London in the United Kingdom. It operates as a subsidiary of Amdipharm Mercury Company as of September 30, 2014.